Management of Hemoptysis in Pulmonary Tuberculosis Patients

Severity Classification and Initial Assessment

The American College of Radiology defines massive hemoptysis as bleeding that places the patient at high risk for asphyxiation or exsanguination, with the rate of bleeding correlating more closely with mortality than total volume 3, 2
Two or more opacified lung quadrants on chest radiograph correlate with increased mortality risk 3, 1, 2
Death from massive hemoptysis occurs more commonly from asphyxiation rather than exsanguination 3
Assess airway patency, hemodynamic stability, and oxygenation status immediately 2

For clinically unstable patients with massive hemoptysis, immediate airway management involves intubation with a single-lumen cuffed endotracheal tube to allow bronchoscopic suctioning and clot removal 1, 2, 4
Establish large-bore IV access for resuscitation 4
Avoid BiPAP as positive pressure can worsen bleeding 4
Proceed directly to bronchial artery embolization (BAE) without bronchoscopy in unstable patients, as delaying BAE significantly increases mortality 1, 2, 4
BAE achieves immediate hemostasis in 73-99% of cases, with tuberculosis showing 87-94% success rates in Asian studies 1, 4

CT chest with IV contrast is the preferred initial diagnostic test, with diagnostic accuracy of 80-90% and superior to bronchoscopy (77% vs 8% diagnostic yield) 1, 2, 4
CT angiography is the standard of care for arterial planning if BAE is being considered 1, 4
Bronchoscopy provides valuable information on anatomic site and side of bleeding, with 70-80% diagnostic yield 2, 4

Administer antibiotics for at least mild hemoptysis (>5 mL), as bleeding may represent a pulmonary exacerbation or superimposed bacterial infection 5, 1, 2
Stop NSAIDs immediately in patients with at least mild hemoptysis, as they impair platelet function and worsen bleeding 5, 1, 2
Stop all anticoagulants during active hemoptysis 2
Stop all airway clearance therapies immediately in massive hemoptysis to allow clot formation 4

All patients should be admitted to intensive care for monitoring of coagulation parameters, hemoglobin levels, blood gases, and ongoing bleeding 1, 4
Actively warm the patient and all transfused fluids, and start venous thromboprophylaxis as soon as bleeding is controlled 4

Recurrence of bleeding occurs in 10-55% of cases after BAE, with higher rates in TB patients compared to other etiologies 1, 2
Aspergillomas have the highest recurrence rate of hemoptysis (55%) after BAE, making definitive surgical treatment necessary following initial BAE for acute massive hemoptysis 1, 4
Repeat BAE interventions show no increased risk of morbidity or mortality 4

Surgery is reserved for specific situations, including when BAE alone is unsuccessful, for aspergillomas with recurrent hemoptysis after initial BAE, and for surgically resectable cavitary lesions in stable patients 4, 1
Surgical mortality for massive hemoptysis is 16%, associated with blood aspiration into contralateral lung and pneumonectomy 4

Never delay airway protection in favor of diagnostic procedures when the patient has respiratory distress 4
Never perform bronchoscopy before BAE in clinically unstable patients with massive hemoptysis 2, 4
Never continue NSAIDs or anticoagulants during active hemoptysis 2
Never use BiPAP in massive hemoptysis as it can worsen bleeding 4

Scant hemoptysis may not require admission and can be managed outpatient 5
Massive hemoptysis should always be admitted to the hospital 5
Mild-to-moderate hemoptysis (10-60 mL) requires individualized assessment, with some patients manageable at home if they have had previous bouts of bleeding 5